Data integrity is key to the success of any cell therapy program. CDMOs can implement robust data management systems for ...

Raw materials play a critical role in cell therapy manufacturing. Choosing suboptimal materials at any stage of development ...

Cellares, which last year became the first company to receive the FDA's new advanced manufacturing technology designation, ...

Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...

Bracco’s cell selection and activation microbubble technology is designed to support both positive- and negative-selection strategies.

Cellares. Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the ...

Bracco Imaging is expanding into the cell therapy space to explore new applications of its long-established microbubble technology.

Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...

Pluri (PLUR), an established global leader in the development and manufacturing of cell-based therapeutics, launches new revenue-generating Contract Development and Manufacturing Organization (CDMO) ...

CaseBioscience® announces the launch of CaseCryo® CTG DMSO , a next-generation cryopreservation solution developed to support ...